Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients.

Tan SY, Najita J, Li X, Strazzulla LC, Dunbar H, Lee MY, Seery VJ, Buchbinder EI, Tawa NE, McDermott DF, Lee SJ, Atkins MB, Kim CC.

Melanoma Res. 2019 Feb;29(1):70-76. doi: 10.1097/CMR.0000000000000483.

PMID:
30169431
2.

Ethics knowledge of recent paediatric residency graduates: the role of residency ethics curricula.

Kesselheim JC, Najita J, Morley D, Bair E, Joffe S.

J Med Ethics. 2016 Dec;42(12):809-814. doi: 10.1136/medethics-2016-103625. Epub 2016 Oct 19.

PMID:
27884969
3.

Sex Differences in Age at Primary Melanoma Diagnosis in a Population-Based Analysis (US Surveillance, Epidemiology, and End Results, 2005-2011).

Najita JS, Swetter SM, Geller AC, Gershenwald JE, Zelen M, Lee SJ.

J Invest Dermatol. 2016 Sep;136(9):1894-1897. doi: 10.1016/j.jid.2016.03.044. Epub 2016 May 29. No abstract available.

4.

Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.

Gray SW, Park ER, Najita J, Martins Y, Traeger L, Bair E, Gagne J, Garber J, Jänne PA, Lindeman N, Lowenstein C, Oliver N, Sholl L, Van Allen EM, Wagle N, Wood S, Garraway L, Joffe S.

Genet Med. 2016 Oct;18(10):1011-9. doi: 10.1038/gim.2015.207. Epub 2016 Feb 11.

5.

Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.

Dang C, Guo H, Najita J, Yardley D, Marcom K, Albain K, Rugo H, Miller K, Ellis M, Shapira I, Wolff AC, Carey LA, Moy B, Groarke J, Moslehi J, Krop I, Burstein HJ, Hudis C, Winer EP, Tolaney SM.

JAMA Oncol. 2016 Jan;2(1):29-36. doi: 10.1001/jamaoncol.2015.3709.

6.

Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast Cancer.

Seah DS, Scott S, Guo H, Najita J, Lederman R, Frank E, Sohl J, Stadler Z, Silverman S, Peppercorn J, Winer E, Come S, Lin NU.

Oncologist. 2015 Sep;20(9):992-1000. doi: 10.1634/theoncologist.2015-0112. Epub 2015 Aug 3.

7.

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).

Lin NU, Guo H, Yap JT, Mayer IA, Falkson CI, Hobday TJ, Dees EC, Richardson AL, Nanda R, Rimawi MF, Ryabin N, Najita JS, Barry WT, Arteaga CL, Wolff AC, Krop IE, Winer EP, Van den Abbeele AD.

J Clin Oncol. 2015 Aug 20;33(24):2623-31. doi: 10.1200/JCO.2014.60.0353. Epub 2015 Jul 13.

8.

Long-term follow-up after preoperative trastuzumab and chemotherapy for HER2-overexpressing breast cancer.

Mayer EL, Gropper AB, Harris L, Gold JM, Parker L, Kuter I, Come S, Najita JS, Guo H, Winer EP, Burstein HJ.

Clin Breast Cancer. 2015 Feb;15(1):24-30. doi: 10.1016/j.clbc.2014.07.010. Epub 2014 Aug 15.

PMID:
25205424
9.

Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort.

Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE, Sklar CA, Robison LL, Diller L.

Lancet Oncol. 2013 Aug;14(9):873-81. doi: 10.1016/S1470-2045(13)70251-1. Epub 2013 Jul 13.

10.

A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer.

Tolaney SM, Najita J, Sperinde J, Huang W, Chen WY, Savoie J, Fornier M, Winer EP, Bunnell C, Krop IE.

Ann Oncol. 2013 Jul;24(7):1841-7. doi: 10.1093/annonc/mdt121. Epub 2013 Apr 4.

11.

Attitudes of patients with metastatic breast cancer toward research biopsies.

Seah DS, Scott SM, Najita J, Openshaw T, Krag K, Frank E, Sohl J, Stadler ZK, Garrett M, Silverman SG, Peppercorn J, Winer EP, Come SE, Lin NU.

Ann Oncol. 2013 Jul;24(7):1853-9. doi: 10.1093/annonc/mdt067. Epub 2013 Mar 13.

12.

Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era.

Olson EM, Najita JS, Sohl J, Arnaout A, Burstein HJ, Winer EP, Lin NU.

Breast. 2013 Aug;22(4):525-31. doi: 10.1016/j.breast.2012.12.006. Epub 2013 Jan 23.

13.

On determining the BMD from multiple outcomes in developmental toxicity studies when one outcome is intentionally missing.

Najita JS, Catalano PJ.

Risk Anal. 2013 Aug;33(8):1500-9. doi: 10.1111/j.1539-6924.2012.01939.x. Epub 2012 Dec 12.

14.

Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting.

Ligibel JA, Meyerhardt J, Pierce JP, Najita J, Shockro L, Campbell N, Newman VA, Barbier L, Hacker E, Wood M, Marshall J, Paskett E, Shapiro C.

Breast Cancer Res Treat. 2012 Feb;132(1):205-13. doi: 10.1007/s10549-011-1882-7. Epub 2011 Nov 24.

15.

Surgery of the primary tumor does not improve survival in stage IV breast cancer.

Dominici L, Najita J, Hughes M, Niland J, Marcom P, Wong YN, Carter B, Javid S, Edge S, Burstein H, Golshan M.

Breast Cancer Res Treat. 2011 Sep;129(2):459-65. doi: 10.1007/s10549-011-1648-2. Epub 2011 Jun 29.

16.

Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer.

Olson EM, Lin NU, DiPiro PJ, Najita JS, Krop IE, Winer EP, Burstein HJ.

Ann Oncol. 2012 Jan;23(1):93-7. doi: 10.1093/annonc/mdr061. Epub 2011 Apr 29.

17.

Breastfeeding in survivors of Hodgkin lymphoma treated with chest radiotherapy.

McCullough L, Ng A, Najita J, Janov A, Henderson T, Mauch P, Diller L.

Cancer. 2010 Oct 15;116(20):4866-71. doi: 10.1002/cncr.25442.

18.

A Novel Application of a Bivariate Regression Model for Binary and Continuous Outcomes to Studies of Fetal Toxicity.

Najita JS, Li Y, Catalano PJ.

J R Stat Soc Ser C Appl Stat. 2009 Sep 1;58(4):555-573.

19.

Health status of the oldest adult survivors of cancer during childhood.

Kenney LB, Nancarrow CM, Najita J, Vrooman LM, Rothwell M, Recklitis C, Li FP, Diller L.

Cancer. 2010 Jan 15;116(2):497-505. doi: 10.1002/cncr.24718.

20.

Suicide ideation in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Recklitis CJ, Diller LR, Li X, Najita J, Robison LL, Zeltzer L.

J Clin Oncol. 2010 Feb 1;28(4):655-61. doi: 10.1200/JCO.2009.22.8635. Epub 2009 Oct 19.

21.

Caring for cancer survivors: a survey of primary care physicians.

Bober SL, Recklitis CJ, Campbell EG, Park ER, Kutner JS, Najita JS, Diller L.

Cancer. 2009 Sep 15;115(18 Suppl):4409-18. doi: 10.1002/cncr.24590.

22.

Lymphopenia associated with adjuvant anthracycline/ taxane regimens.

Tolaney SM, Najita J, Winer EP, Burstein HJ.

Clin Breast Cancer. 2008 Aug;8(4):352-6. doi: 10.3816/CBC.2008.n.041.

PMID:
18757263
23.

Organic molecules and water in the planet formation region of young circumstellar disks.

Carr JS, Najita JR.

Science. 2008 Mar 14;319(5869):1504-6. doi: 10.1126/science.1153807.

24.

The development of a protoplanetary disk from its natal envelope.

Watson DM, Bohac CJ, Hull C, Forrest WJ, Furlan E, Najita J, Calvet N, d'Alessio P, Hartmann L, Sargent B, Green JD, Kim KH, Houck JR.

Nature. 2007 Aug 30;448(7157):1026-8.

25.

Ethnic differences in risk for pediatric rheumatic illness in a culturally diverse population.

Kurahara D, Tokuda A, Grandinetti A, Najita J, Ho C, Yamamoto K, Reddy DV, Macpherson K, Iwamuro M, Yamaga K.

J Rheumatol. 2002 Feb;29(2):379-83.

PMID:
11838859
26.

Extra-solar planetary systems.

Najita J, Benz W, Hatzes A.

Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14197-8. No abstract available.

27.

Sensitivity study on hydraulic well testing inversion using simulated annealing.

Nakao S, Najita J, Karasaki K.

Ground Water. 1999 Sep-Oct;37(5):736-47. doi: 10.1111/j.1745-6584.1999.tb01166.x.

PMID:
19125927

Supplemental Content

Loading ...
Support Center